Literature DB >> 11095857

Aspects of Pulmonary Infections After Solid Organ Transplantation.

.   

Abstract

The increasing number of solid organ transplant (SOT) recipients have high rates of pulmonary infections due to bacterial, fungal, and viral pathogens. These patients have unique sets of factors predisposing to infection. Lung and heart-lung transplants are associated with particularly high infection rates. The prominence of cytomegalovirus (CMV) as a pathogen in all subsets of SOT patients has led to new strategies for prophylaxis, detection, and treatment of CMV pneumonitis. Progress is similarly being made in managing fungal and bacterial infections. Advances in liver, kidney, heart, and lung transplantation are being discussed, with further attention to specific pathogens (ie, CMV, Aspergillus, Pneumocystis carinii, and Mycobacterium tuberculosis).

Entities:  

Year:  2000        PMID: 11095857     DOI: 10.1007/s11908-000-0036-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  34 in total

Review 1.  Invasive aspergillosis in transplant recipients.

Authors:  D L Paterson; N Singh
Journal:  Medicine (Baltimore)       Date:  1999-03       Impact factor: 1.889

2.  Semiquantitative measurement of cytomegalovirus DNA in lung and heart-lung transplant patients by in vitro DNA amplification.

Authors:  P T Cagle; G Buffone; V A Holland; T Samo; G J Demmler; G P Noon; E C Lawrence
Journal:  Chest       Date:  1992-01       Impact factor: 9.410

Review 3.  Lung transplantation: implications for the general internist.

Authors:  D R Nunley; J H Dauber
Journal:  Adv Intern Med       Date:  1996

4.  The prevention of invasive aspergillosis--a realistic goal?

Authors:  R J Hay
Journal:  J Antimicrob Chemother       Date:  1993-10       Impact factor: 5.790

Review 5.  Pneumocystis carinii and parasitic infections in transplantation.

Authors:  J A Fishman
Journal:  Infect Dis Clin North Am       Date:  1995-12       Impact factor: 5.982

6.  Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

Authors:  D Lowance; H H Neumayer; C M Legendre; J P Squifflet; J Kovarik; P J Brennan; D Norman; R Mendez; M R Keating; G L Coggon; A Crisp; I C Lee
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

7.  Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?

Authors:  S M Gordon; S P LaRosa; S Kalmadi; A C Arroliga; R K Avery; L Truesdell-LaRosa; D L Longworth
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

8.  Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole.

Authors:  S L Olsen; D G Renlund; J B O'Connell; D O Taylor; J E Lassetter; T E Eastburn; E H Hammond; M R Bristow
Journal:  Transplantation       Date:  1993-08       Impact factor: 4.939

9.  Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin.

Authors:  D J Conti; B M Freed; S A Gruber; N Lempert
Journal:  Arch Surg       Date:  1994-04

Review 10.  Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

Authors:  M Boeckh; G Boivin
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.